Science News

Chronic Constipation Study Offers Relief To All Sufferers

ScienceDaily (June 24, 2007) — A clinical trial including 50 medical centers and 304 patients has confirmed that polyethylene (PEG) laxative is safe for patients suffering from chronic constipation. The study, published in The American Journal of Gastroenterology, indicates that even elderly patients can use the drug safely for up to six months.

“Until recently, few data were available regarding the long term treatment of chronic constipation,” says study author Dr. Jack DiPalma. “Only two medications are currently approved by the FDA for treatment of this condition.”

The study was a double-blinded, placebo-controlled trial. 52 percent of patients taking PEG responded successfully to treatment, compared to 11 percent of those taking the placebo. Similar results were observed when analyzed for differences due to gender, race and age.

Although some patients did show slight side effects, there was no significant difference between the PEG-treated and placebo groups.

This study is published in the July issue of The American Journal of Gastroenterology.


Adapted from materials provided by Blackwell Publishing Ltd..
APA

MLA

Search ScienceDaily

Number of stories in archives: 44,032

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily's archives for related news topics,
the latest news stories, reference articles, science videos, images, and books.
 

Science Video News


Breathing Easier

Half of all lung transplant patients don't live past the fifth year after the procedure, due in part to chronic rejection of the new organs. A new,. ...  > full story

Breaking News

... from NewsDaily.com

In Other News ...

Copyright Reuters 2008. See Restrictions.

Free Subscriptions

... from ScienceDaily

Get the latest science news with our free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Feedback

... we want to hear from you!

Tell us what you think of the new ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Post this page to your favorite social bookmarking site:
close
Include this item in your blog or web site:
close
Cite this article in your essay, paper, or report:
close
Email this page's link to a friend or colleague:
close